Campbell & Co Investment Adviser’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $55.6K | Sell |
10,469
-10,721
| -51% | -$56.9K | ﹤0.01% | 1099 |
|
2025
Q1 | $188K | Sell |
21,190
-105,795
| -83% | -$938K | 0.01% | 951 |
|
2024
Q4 | $1.74M | Buy |
+126,985
| New | +$1.74M | 0.13% | 219 |
|
2024
Q3 | – | Sell |
-21,617
| Closed | -$529K | – | 1244 |
|
2024
Q2 | $529K | Buy |
+21,617
| New | +$529K | 0.05% | 632 |
|
2019
Q3 | – | Sell |
-16,119
| Closed | -$448K | – | 702 |
|
2019
Q2 | $448K | Buy |
+16,119
| New | +$448K | 0.2% | 173 |
|
2016
Q3 | – | Sell |
-9,902
| Closed | -$303K | – | 173 |
|
2016
Q2 | $303K | Buy |
+9,902
| New | +$303K | 1.53% | 18 |
|